PORTLAND, Ore., March 20 /PRNewswire-FirstCall/ --
Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of
needle-free drug delivery systems, announced today that Company management
will make a presentation to analysts and portfolio managers at The New York
Society of Security Analysts (NYSSA) Sixth Annual Health Care Conference in
New York City on Tuesday, March 26, 2002 at 3:30 PM Eastern Standard Time.
Approximately 30 public companies will be presenting at the Conference from
March 25 through March 27, 2002. Analysts and portfolio managers who wish to
attend the presentation should contact the NYSSA at 212-541-4406, or register
at http://www.nyssa.org/events/healthcare2002.html .
Investors may also access an Internet web cast of the presentation at:
http://www.twst.com/econf/mm/nyssa4/bjct.html
About Bioject
Bioject Medical Technologies Inc., based in Portland, Oregon, is an
innovative developer and manufacturer of needle-free drug delivery systems.
Bioject's strategic partners include Serono and Alkermes. Needle-free
injection works by forcing medication at high speed through a tiny orifice
held against the skin. This creates a fine stream of high-pressure fluid
penetrating the skin and depositing medication in the tissue beneath.
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks, uncertainties and other factors
that may cause the actual results, performance or achievements of the company,
or industry results, to be materially different from any future results,
performance, or achievements expressed or implied by such forward-looking
statements. Readers of this press release are referred to the Company's
filings with the Securities and Exchange Commission, including the Company's
reports on Forms 10-K and Forms 10-Q for further discussions of factors that
could affect future results. Forward-looking statements are based on the
estimates and opinions of management on the date the statements are made. The
Company assumes no obligation to update forward-looking statements if
conditions or management's estimates or opinions should change.
For more information about Bioject, visit http://www.bioject.com.
SOURCE Bioject Medical Technologies Inc.
 back to top
Related links:
http://www.bioject.com
Company News On-Call:
http://www.prnewswire.com/comp/101750.html
CONTACT:
Cecelia C. Heer, Investor Relations Manager
of Bioject Medical Technologies Inc., +1-973-605-8554 or
cheer@bioject.com; or IR/Media, Jim Flanagan of IR Strategic
Advisors, +1-781-863-1333 or jflanagan@iradvisors.com
|
